Cs Diagnostics Corp. financial data

Symbol
CSDX on OTC
Location
Stresemannallee 4 B, Neuss, Germany
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137M shares
Common Stock, Shares, Outstanding 137M shares
Common Stock, Value, Issued 1.37K USD
Weighted Average Number of Shares Outstanding, Basic 137M shares +5.89%
Weighted Average Number of Shares Outstanding, Diluted 137M shares +5.89%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 23.1K USD +189%
Research and Development Expense 0 USD
General and Administrative Expense 70 USD 0%
Operating Income (Loss) -182 USD -134%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 31K USD
Assets 499M USD
Accounts Payable, Current 1.61K USD
Liabilities 1.61K USD
Retained Earnings (Accumulated Deficit) -4.74M USD
Stockholders' Equity Attributable to Parent 499M USD
Liabilities and Equity 499M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 250M shares
Common Stock, Shares, Issued 137M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13 USD -100%
Additional Paid in Capital 504M USD